Use of FLT3 ligand for enhancing immune responses in RNA immunization

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9486519
APP PUB NO 20110311584A1
SERIAL NO

13139034

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to supplying vaccine RNA to cells. The invention relates in particular to a common use of vaccine RNA and Flt3 ligand for inducing, creating or enhancing an immune response when administered to animals (including humans).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TRON- TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GEMEINNUTZIGE GMBHFREILIGRATHSTRASSE 12 MAINZ 55131

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kreiter, Sebastian Mainz, DE 36 509
Sahin, Ugur Mainz, DE 331 2329
Selmi, Abderraouf Mainz, DE 1 24
Türeci, Özlem Mainz, DE 76 516

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 8, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00